Carofiglio, F.; Lopalco, A.; Lopedota, A.; Cutrignelli, A.; Nicolotti, O.; Denora, N.; Stefanachi, A.; Leonetti, F.
Bcr-Abl Tyrosine Kinase Inhibitors in the Treatment of Pediatric CML. Int. J. Mol. Sci. 2020, 21, 4469.
https://doi.org/10.3390/ijms21124469
AMA Style
Carofiglio F, Lopalco A, Lopedota A, Cutrignelli A, Nicolotti O, Denora N, Stefanachi A, Leonetti F.
Bcr-Abl Tyrosine Kinase Inhibitors in the Treatment of Pediatric CML. International Journal of Molecular Sciences. 2020; 21(12):4469.
https://doi.org/10.3390/ijms21124469
Chicago/Turabian Style
Carofiglio, Francesca, Antonio Lopalco, Angela Lopedota, Annalisa Cutrignelli, Orazio Nicolotti, Nunzio Denora, Angela Stefanachi, and Francesco Leonetti.
2020. "Bcr-Abl Tyrosine Kinase Inhibitors in the Treatment of Pediatric CML" International Journal of Molecular Sciences 21, no. 12: 4469.
https://doi.org/10.3390/ijms21124469
APA Style
Carofiglio, F., Lopalco, A., Lopedota, A., Cutrignelli, A., Nicolotti, O., Denora, N., Stefanachi, A., & Leonetti, F.
(2020). Bcr-Abl Tyrosine Kinase Inhibitors in the Treatment of Pediatric CML. International Journal of Molecular Sciences, 21(12), 4469.
https://doi.org/10.3390/ijms21124469